The PE Ratio as of December 2025 (TTM) for Xbrane Biopharma AB (publ) (XBRANE.ST) is -0.72

According to Xbrane Biopharma AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.72. This represents a change of -235.85% compared to the average of 0.53 of the last 4 quarters.

Xbrane Biopharma AB (publ) (XBRANE.ST) Historical PE Ratio (quarterly & annually)

How has XBRANE.ST PE Ratio performed in the past?

The mean historical PE Ratio of Xbrane Biopharma AB (publ) over the last ten years is -67.51. The current -0.72 PE Ratio has changed 6.65% with respect to the historical average. Over the past ten years (40 quarters), XBRANE.ST's PE Ratio was at its highest in in the September 2018 quarter at 11.80. The PE Ratio was at its lowest in in the December 2021 quarter at -173.07.

Xbrane Biopharma AB (publ) (XBRANE.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Xbrane Biopharma AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xbrane Biopharma AB (publ) (XBRANE.ST) Average PE Ratio

How has XBRANE.ST PE Ratio performed in the past?

The current PE Ratio of Xbrane Biopharma AB (publ) (XBRANE.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Xbrane Biopharma AB (publ) (XBRANE.ST) PE Ratio vs. Peers

How is XBRANE.ST’s PE Ratio compared to its peers?

Xbrane Biopharma AB (publ)’s PE Ratio is greater than Scandinavian ChemoTech AB (publ) (-12.42), less than Biovica International AB (publ) (-0.41), greater than Nanologica AB (publ) (-1.34), greater than Alzinova AB (publ) (-5.77), greater than Active Biotech AB (publ) (-1.44), greater than Biosergen AB (-3.16), greater than SciBase Holding AB (publ) (-1.59), greater than Neola Medical AB (publ) (-7.87), greater than NextCell Pharma AB (-2.09), greater than AcuCort AB (-5.73),

Build a custom stock screener for Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xbrane Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xbrane Biopharma AB (publ) (XBRANE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xbrane Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.